cencora

Pharmaceutical distribution and healthcare solutions provider

Pennsylvania, United States

About cencora

Cencora is a global pharmaceutical solutions organization that focuses on enhancing healthcare for both people and animals. The company provides a wide range of services, including drug distribution, specialty pharmacy services, and consulting, which help healthcare providers, pharmaceutical manufacturers, and veterinary practices improve efficiency and patient outcomes. Cencora's business model is centered around offering value-added services, generating revenue through pharmaceutical distribution, consulting, and patient support programs. What sets Cencora apart from its competitors is its commitment to social responsibility, exemplified by its $100 million investment in Project Black, which aims to foster minority-owned businesses. The company's goal is to advance pharmaceutical care while adhering to Environmental, Social, and Governance (ESG) principles.

None, PennsylvaniaHeadquarters

1907Year Founded

IPOCompany Stage

Consulting, Social Impact, HealthcareIndustries

5,001-10,000Employees

Risks

Cencora's $75 million ransomware payment reveals cybersecurity vulnerabilities.

Retina Consultants acquisition increases financial leverage, risking balance sheet strain.

Governance issues from past court cases could impact Cencora's reputation.

Differentiation

Cencora integrates drug distribution with specialty pharmacy and consulting services.

The company offers a unique combination of supply chain management and data analytics.

Cencora's ESG initiatives, like Project Black, set it apart in sustainability efforts.

Upsides

Growing demand for specialty pharmacy services boosts Cencora's market share.

Telehealth trends offer Cencora new digital integration opportunities.

Personalized medicine aligns with Cencora's data analytics and patient support capabilities.

Funding

Total raised$1.0 K

StageIPO

POST IPO DEBT

1/31/2024

$500

POST IPO SECONDARY

10/31/2022